sorry, we can't preview this file

13195_2021_927_MOESM1_ESM.xlsx (14.66 kB)

Additional file 1 of The Alzheimer’s disease drug development landscape

dataset

posted on 2021-11-12, 04:24 authored by Pieter van Bokhoven, Arno de Wilde, Lisa Vermunt, Prisca S. Leferink, Sasja Heetveld, Jeffrey Cummings, Philip Scheltens, Everard G. B. Vijverberg

Additional file 1 : Table S1. Number of drugs in preclinical (pre) and clinical (clin) development for AD, stratified by target class and treatment modality.